Christine Gebski - 01 Sep 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
SVP, Filtration & Chromatography
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
01 Sep 2021
Net transactions value
-$963,559
Form type
4
Filing time
02 Sep 2021, 16:33:36 UTC
Previous filing
18 May 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale $963,559 -3,377 -9.2% $285.33 33,318 01 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $285.33 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.16 to $285.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

SVP, Filtration & Chromatography